You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指跌幅曾擴至逾600點險守牛熊線 濠賭及中資保險股捱沽
阿思達克 01-23 14:02
中國武漢市新型冠狀病毒感染肺炎確診個案最新續增至571宗,死亡病例增至17宗,武漢市今早10時起「封城」。美股期貨全面反覆受壓,昨晚逆市倒跌的道指期貨報29,083,反覆續跌57點或0.2%。亞太區主要股市普遍受壓,尤其是滬指及深成午後低見2,960及10,572,現造2,970及10,639,急吐2.9%及3.9%。 本港首次出現兩宗高度懷疑感染武漢肺炎個案。恆指繼昨天彈近1.3%受制28,400後,今天低開231點,跌幅持續曾擴至626點或2.2%,低見27,714,險守牛熊線(27,704),現造27,764,急吐576點或2%,成交額已達786億元。 藍籌股無一倖免,跌幅普遍逾1%-3%。擬發7.5億歐元零息可換股債券的中生製藥(01177.HK)沽壓最大,股價失守10天線,最低見11.4元,現造11.42元,急吐5.8%。石藥(01093.HK)由今早高位19.68元,掉頭低見18.68元,現造18.78元,倒跌3.6%。 聯通(00762.HK)業績快報料去年純利按年增近11%至113億人民幣,該股失守50天及10天線(7.09-7.13元),報6.83元,挫4.3%。此外,吉利(00175.HK)失守牛熊線(13.92元),最低見13.44元,現造13.48元,挫4.4%。三大科技股跌逾2.5%-4%,瑞聲(02018.HK)沽壓最大,報61.8元。 澳門確診第二宗武漢肺炎,金沙(01928.HK)及銀娛(00027.HK)低見40元及54.5元,現造40.45元及54.8元,跌3.6%及4.9%,後者失守50天線(55.88元)。非藍籌永利(01128.HK)、澳博(00880.HK)、美高梅(02282.HK)及新濠(00200.HK)也挫4.2%-6%,分別報17.94元/9.12元/12.28元/18.46元。 憂武漢肺死亡病例續增拖累理賠個案上升,國壽(02628.HK)跌破50天線(21.09元),最低見20.35元,現造20.5元,挫4%;中國平安(02318.HK)失守10天線(95.8元),最低見93元,現造93.35元,跌2.8%。(sz/t)~ 阿思達克財經新聞 網址: www.aastocks.com
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account